Compare ZM & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZM | GEHC |
|---|---|---|
| Founded | 2011 | 1892 |
| Country | United States | United States |
| Employees | N/A | 54000 |
| Industry | Computer Software: Programming Data Processing | Computer Software: Prepackaged Software |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.0B | 29.1B |
| IPO Year | 2019 | 2022 |
| Metric | ZM | GEHC |
|---|---|---|
| Price | $91.05 | $66.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 13 |
| Target Price | ★ $94.14 | $88.38 |
| AVG Volume (30 Days) | ★ 3.2M | 2.8M |
| Earning Date | 05-21-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ 92.52 | 4.84 |
| EPS | ★ 6.56 | 0.85 |
| Revenue | $4,868,769,000.00 | ★ $20,625,000,000.00 |
| Revenue This Year | $7.30 | $7.12 |
| Revenue Next Year | $3.96 | $4.45 |
| P/E Ratio | ★ $13.87 | $76.25 |
| Revenue Growth | 4.36 | ★ 4.84 |
| 52 Week Low | $70.70 | $58.75 |
| 52 Week High | $114.74 | $89.77 |
| Indicator | ZM | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 42.45 | 45.44 |
| Support Level | $86.74 | $60.17 |
| Resistance Level | $95.76 | $72.77 |
| Average True Range (ATR) | 2.75 | 1.46 |
| MACD | -0.72 | -0.25 |
| Stochastic Oscillator | 29.09 | 38.23 |
Zoom Communications provides a video-first communications platform that connects people through frictionless video, voice, chat, and content sharing. The company's cloud-native platform enables video experiences and connects users across various devices and locations in a single meeting. Zoom has launched a variety of communications-related solutions, including Zoom Phone and Zoom Contact Center. The firm was founded in 2011 and serves companies of all sizes from all industries around the world.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).